Thompson Davis & Co’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q4 | – | Sell |
-112,768
| Closed | -$365K | – | 1159 |
|
2017
Q3 | $365K | Sell |
112,768
-79,966
| -41% | -$259K | 0.65% | 25 |
|
2017
Q2 | $621K | Buy |
192,734
+124,348
| +182% | +$401K | 1% | 17 |
|
2017
Q1 | $194K | Buy |
68,386
+30,560
| +81% | +$86.7K | 0.28% | 83 |
|
2016
Q4 | $88K | Buy |
37,826
+23,232
| +159% | +$54K | 0.15% | 158 |
|
2016
Q3 | $25K | Sell |
14,594
-4,827
| -25% | -$8.27K | 0.04% | 403 |
|
2016
Q2 | $20K | Buy |
+19,421
| New | +$20K | 0.03% | 475 |
|
2015
Q1 | – | Sell |
-7,000
| Closed | -$18K | – | 1305 |
|
2014
Q4 | $18K | Hold |
7,000
| – | – | 0.02% | 554 |
|
2014
Q3 | $13K | Sell |
7,000
-29,500
| -81% | -$54.8K | 0.02% | 617 |
|
2014
Q2 | $97K | Hold |
36,500
| – | – | 0.14% | 180 |
|
2014
Q1 | $128K | Hold |
36,500
| – | – | 0.21% | 120 |
|
2013
Q4 | $163K | Buy |
+36,500
| New | +$163K | 0.25% | 96 |
|